Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2021 · 10-Q
Revenue$7.21M$7.21M−8.5% vs Q2 2020 Net Income$1.17M$1.17M+22.8% vs Q2 2020 EPS Diluted$0.14$0.14+16.7% vs Q2 2020 Operating Income$1,995,068+13.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,526,814+96.0% Margins · derivedOperating margin27.7%+5.4 pt vs Q2 2020
Net margin16.2%+4.1 pt vs Q2 2020
ended May 31, 2021 · filed Jul 15, 2021 · 45 d after period end